Marius Miglinas

Novel transcriptomic signatures associated with premature kidney allograft failure

D. Maixnerova, O. Viklicky, L. Voska, 2023, EBioMedicine.

Subthreshold rejection activity in many kidney transplants currently classified as having no rejection

L. Domański, M. Myślak, A. Perkowska-Ptasinska, 2024, American Journal of Transplantation.

Endobiogenic Biology of Function Indices in a Cohort of Kidney Transplant Recipients

D. Serapinas, E. Mačionienė, Marius Miglinas, 2024, Medicina.

A Prospective Study on the Impact of Clinical Factors and Adjusted Triple D System for Success Rate of ESWL

V. Šablinskas, A. Želvys, V. Urbonienė, 2023, Medicina.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.